Close Menu

NEW YORK – The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) recently published a set of guidelines for in vitro diagnostics manufacturers in the event that the UK leaves the European Union without a deal.

British Prime Minister Boris Johnson has reiterated that the UK will exit the EU by the end of the month with or without a deal. If the UK does leave the EU on Oct. 31 without a deal, MHRA will take on the responsibilities for regulating medical devices and IVDs currently overseen by the EU.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.